戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nt oral and genital ulceration, uveitis, and erythema nodosum.
2 ed oral ulcers (100%), genital ulcers (62%), erythema nodosum (46%), and papulopustular lesions (54%)
3                The initial presentation with erythema nodosum and periarthritis due to infection with
4 hiolitis obliterans organizing pneumonia and erythema nodosum are immunologic diseases that have not
5 itis, oral aphthous ulcers, episcleritis, or erythema nodosum can be associated with active intestina
6 e likely to have skin involvement other than erythema nodosum (chi(2) = 5.47, p < 0.05), and eye (chi
7  chi(2) = 4.60, p < 0.05 respectively), have erythema nodosum (chi(2) = 7.28, p < 0.01), and to be ag
8                                       Unlike erythema nodosum (EN) and pyoderma gangrenosum (PG), LCV
9 ral history or immunogenetic associations of erythema nodosum (EN) or ocular inflammation in inflamma
10 osition -308 was found to be associated with erythema nodosum in Caucasian sarcoidosis patients (stud
11  a gene adjacent to TNF, was associated with erythema nodosum in female Caucasian sarcoidosis patient
12 rcoidosis and may explain the higher rate of erythema nodosum in females with sarcoidosis.
13 ariant has individually been associated with erythema nodosum in sarcoidosis patients.
14 e is clinically valuable in the treatment of erythema nodosum leprosum (ENL) and multiple myeloma and
15 nts when evaluated before the onset of acute erythema nodosum leprosum (ENL) and persistently elevate
16 g thalidomide is the treatment of choice for erythema nodosum leprosum (ENL), an inflammatory cutaneo
17                                           In erythema nodosum leprosum (ENL), which occurs in patient
18 pted by acute inflammatory episodes known as erythema nodosum leprosum (ENL).
19 immune reactions, reversal reaction (RR) and erythema nodosum leprosum (ENL).
20  associated with increased susceptibility to erythema nodosum leprosum in an allelic analysis, wherea
21 lutarimide) therapy in leprosy patients with erythema nodosum leprosum is thought to be due to inhibi
22 sal) reactions and 124 patients with type 2 (erythema nodosum leprosum) reactions.
23 s "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical
24 lammatory and autoimmune disorders including erythema nodosum leprosum, Behcet's syndrome, discoid lu
25  therapeutically in conditions as diverse as erythema nodosum leprosum, chronic graft-vs-host disease
26 nagement of various disease states including erythema nodosum leprosum, for which it was approved by
27 an investigational agent in the treatment of erythema nodosum leprosum, oral ulcers, graft versus hos
28 noted: fever, sialadenitis, lymphadenopathy, erythema nodosum, leukocytoclastic vasculitis, transient
29  nodes (3.7%-9.0%), hyperhidrosis (<2%), and erythema nodosum (&lt;2%) were particularly suggestive of f
30 h nodes (3.7-9.0%), hyperhidrosis (<2%), and erythema nodosum (&lt;2%) were particularly suggestive of f
31 e classic Lofgren syndrome with accompanying erythema nodosum, may be self-limited or may become chro
32 ease course (Pcombined = 5.94 x 10(-7)), and erythema nodosum (Pcombined = 2.27 x 10(-6)), respective
33                 After initial item deletion (Erythema nodosum, Pyoderma gangrenosum), a 7-item scale
34 hiolitis obliterans organizing pneumonia and erythema nodosum simultaneously, several weeks after smo
35 wn role in inflammation were associated with erythema nodosum status in 659 sarcoidosis patients and
36 IV was followed 13 months later by recurrent erythema nodosum with joint effusion.